Loading asset research
Q3 2026 earnings · Oct 30
AbbVie Inc. Common Stock
ABBVNYSE · USD · StocksQuote as of · Exchange session not verified$263.82
+0.41%
Today
Next earnings call
Next earnings call
In 42 days
2026-10-30
Fiscal period
Q3 2026
EPS estimate
— / ($3.86 est.)
Revenue estimate
— / (— est.)
Timing
unknown
EPS vs. consensus estimate
- Actual
- Estimate
Q3 24FY 24Q1 25Q2 25Q3 25FY 25Q1 26Q2 26
Revenue vs. consensus estimate
- Actual
- Estimate
Q3 23FY 23Q1 24Q2 24Q3 24FY 24Q1 25Q2 25
EPS surprise history
Q3 25Q2 26
Beat or met consensus in 100% of the last 4 reported quarters.
Previous reports
Values are converted from USD into your selected display currency. Actuals are drawn from SEC filings (XBRL) and Yahoo statements; estimates and surprises from Nasdaq where available.
| Fiscal period | Report date | Normalized EPS | EPS surprise | Revenue | Rev. surprise | Actions |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 31, 2026 | $3.65 / ($3.64 est.) | +0.27% | 16,990,000,000 (unit unavailable) / (— est.) | — | Source |
| Q1 2026 | Apr 29, 2026 | $2.65 / ($2.62 est.) | +1.15% | 15,002,000,000 (unit unavailable) / (— est.) | — | Source |
| FY 2025 | Feb 4, 2026 | $2.71 / ($2.66 est.) | +1.88% | 16,618,000,000 (unit unavailable) / (— est.) | — | Source |
| Q3 2025 | Oct 31, 2025 | $1.86 / ($1.77 est.) | +5.08% | 15,776,000,000 (unit unavailable) / (— est.) | — | Source |
| Q2 2025 | Jul 31, 2025 | $0.52 / (— est.) | — | $15.4B / (— est.) | — | Source |
| Q1 2025 | Apr 25, 2025 | $0.72 / (— est.) | — | $13.3B / (— est.) | — | Source |
| FY 2024 | Jan 6, 2025 | -$0.02 / (— est.) | — | $15.1B / (— est.) | — | Source |
| Q3 2024 | Oct 30, 2024 | $0.88 / (— est.) | — | $14.5B / (— est.) | — | Source |
| Q2 2024 | Jul 25, 2024 | $0.77 / (— est.) | — | $14.5B / (— est.) | — | Source |
| Q1 2024 | Apr 26, 2024 | $0.77 / (— est.) | — | $12.3B / (— est.) | — | Source |
| FY 2023 | Jan 5, 2024 | $0.46 / (— est.) | — | $14.3B / (— est.) | — | Source |
| Q3 2023 | Oct 27, 2023 | $1.00 / (— est.) | — | $13.9B / (— est.) | — | Source |
| Q2 2023 | Jul 6, 2023 | $1.14 / (— est.) | — | $13.9B / (— est.) | — | Source |
| Q1 2023 | Apr 5, 2023 | $0.13 / (— est.) | — | $12.2B / (— est.) | — | Source |
| FY 2022 | Jan 6, 2023 | $1.38 / (— est.) | — | $15.1B / (— est.) | — | Source |
| Q3 2022 | Oct 5, 2022 | $2.21 / (— est.) | — | $14.8B / (— est.) | — | Source |
| Q2 2022 | Jul 6, 2022 | $0.51 / (— est.) | — | $14.6B / (— est.) | — | Source |
| Q1 2022 | Apr 21, 2022 | $2.51 / (— est.) | — | $13.5B / (— est.) | — | Source |
| FY 2021 | Feb 2, 2022 | $2.26 / (— est.) | — | $14.9B / (— est.) | — | Source |
| Q3 2021 | Oct 29, 2021 | $1.78 / (— est.) | — | $14.3B / (— est.) | — | Source |
| Q2 2021 | Jul 30, 2021 | $0.42 / (— est.) | — | $14B / (— est.) | — | Source |
| Q1 2021 | Apr 30, 2021 | $1.99 / (— est.) | — | $13B / (— est.) | — | Source |
| FY 2020 | Feb 3, 2021 | $0.01 / (— est.) | — | $13.9B / (— est.) | — | Source |
| Q3 2020 | Oct 30, 2020 | $1.29 / (— est.) | — | $12.9B / (— est.) | — | Source |
| Q2 2020 | Jul 29, 2020 | -$0.46 / (— est.) | — | $10.4B / (— est.) | — | Source |
| Q1 2020 | May 1, 2020 | $2.02 / (— est.) | — | $8.6B / (— est.) | — | Source |
| FY 2019 | Feb 7, 2020 | $1.88 / (— est.) | — | $8.7B / (— est.) | — | Source |
| Q3 2019 | Nov 1, 2019 | $1.26 / (— est.) | — | $8.5B / (— est.) | — | Source |
| Q2 2019 | Jul 26, 2019 | $0.49 / (— est.) | — | $8.3B / (— est.) | — | Source |
| Q1 2019 | Apr 25, 2019 | $1.65 / (— est.) | — | $7.8B / (— est.) | — | Source |
| FY 2018 | Jan 25, 2019 | -$1.23 / (— est.) | — | $8.3B / (— est.) | — | Source |
| Q3 2018 | Nov 2, 2018 | $1.81 / (— est.) | — | $8.2B / (— est.) | — | Source |
| Q2 2018 | Jul 27, 2018 | $1.26 / (— est.) | — | $8.3B / (— est.) | — | Source |
| Q1 2018 | Apr 26, 2018 | $1.74 / (— est.) | — | $7.9B / (— est.) | — | Source |
| FY 2017 | Jan 26, 2018 | $0.03 / (— est.) | — | $7.7B / (— est.) | — | Source |
| Q3 2017 | Oct 27, 2017 | $1.01 / (— est.) | — | $7B / (— est.) | — | Source |
| Q2 2017 | Jul 28, 2017 | $1.19 / (— est.) | — | $6.9B / (— est.) | — | Source |
| Q1 2017 | Apr 27, 2017 | $1.06 / (— est.) | — | $6.5B / (— est.) | — | Source |
| FY 2016 | Jan 27, 2017 | $0.85 / (— est.) | — | $6.8B / (— est.) | — | Source |
| Q3 2016 | Oct 28, 2016 | $0.97 / (— est.) | — | $6.4B / (— est.) | — | Source |
| Q2 2016 | Jul 29, 2016 | $0.98 / (— est.) | — | $6.5B / (— est.) | — | Source |
| Q1 2016 | May 6, 2016 | 0.83 (unit unavailable) / (— est.) | — | 5,958,000,000 (unit unavailable) / (— est.) | — | — |
| FY 2015 | Feb 19, 2016 | 0.92 (unit unavailable) / (— est.) | — | 6,400,000,000 (unit unavailable) / (— est.) | — | — |
| Q3 2015 | Nov 6, 2015 | 0.74 (unit unavailable) / (— est.) | — | 5,944,000,000 (unit unavailable) / (— est.) | — | — |
| Q2 2015 | Aug 7, 2015 | 0.83 (unit unavailable) / (— est.) | — | 5,475,000,000 (unit unavailable) / (— est.) | — | — |
| Q1 2015 | May 8, 2015 | 0.63 (unit unavailable) / (— est.) | — | 5,040,000,000 (unit unavailable) / (— est.) | — | — |
| FY 2014 | Feb 20, 2015 | -0.51 (unit unavailable) / (— est.) | — | 5,452,000,000 (unit unavailable) / (— est.) | — | — |
| Q3 2014 | Nov 7, 2014 | 0.31 (unit unavailable) / (— est.) | — | 5,019,000,000 (unit unavailable) / (— est.) | — | — |
| Q2 2014 | Aug 7, 2014 | 0.68 (unit unavailable) / (— est.) | — | 4,926,000,000 (unit unavailable) / (— est.) | — | — |
| Q1 2014 | May 9, 2014 | 0.61 (unit unavailable) / (— est.) | — | 4,563,000,000 (unit unavailable) / (— est.) | — | — |
| FY 2013 | Feb 21, 2014 | 0.7 (unit unavailable) / (— est.) | — | 5,111,000,000 (unit unavailable) / (— est.) | — | — |
| Q3 2013 | Nov 12, 2013 | 0.6 (unit unavailable) / (— est.) | — | 4,658,000,000 (unit unavailable) / (— est.) | — | — |
| Q2 2013 | Aug 9, 2013 | 0.66 (unit unavailable) / (— est.) | — | 4,692,000,000 (unit unavailable) / (— est.) | — | — |
| Q1 2013 | May 8, 2013 | 0.6 (unit unavailable) / (— est.) | — | 4,329,000,000 (unit unavailable) / (— est.) | — | — |
Regulatory filings
Company reports filed with the SEC.